We screened the presence of anti-FLOT-1/2 antibodies in 282 patients fulfilling diagnostic criteria for multiple sclerosis (252 sera and 50 CSF), and 260 controls (including healthy donors and patients with other neurological disorders). This evidence concerns the gene FLOT1 and nervous system disorder.